Cargando…

DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization

Neovascularization is a prominent cause of irreversible blindness in a variety of ocular diseases. Current therapies for pathological neovascularization are concentrated on the suppression of vascular endothelial growth factors (VEGF). Despite the remarkable efficacy of anti-VEGF drugs, several prob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huiying, Li, Bo, Ding, Jingjuan, Ye, Rong, Xu, Zhijian, Zhang, Qiuyang, Feng, Siguo, Jiang, Qin, Zhu, Weiliang, Yan, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747701/ https://www.ncbi.nlm.nih.gov/pubmed/36513701 http://dx.doi.org/10.1038/s41598-022-25811-0

Ejemplares similares

Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903
por: Ding, Jingjuan, et al.
Publicado: (2022)

Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple Myeloma
por: Feng, Qilin, et al.
Publicado: (2020)

Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma
por: Gao, Minjie, et al.
Publicado: (2017)

A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway
por: Gao, Xuejie, et al.
Publicado: (2021)

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
por: Wang, Yingcong, et al.
Publicado: (2023)

DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway
por: Sun, Xi, et al.
Publicado: (2017)

A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
por: Hu, Liangning, et al.
Publicado: (2020)

Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats
por: Nentwig, Todd B., et al.
Publicado: (2022)

DCZ0814 induces apoptosis and G0/G1 phase cell cycle arrest in myeloma by dual inhibition of mTORC1/2
por: Kong, Yuanyuan, et al.
Publicado: (2019)

A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway
por: Lu, Kang, et al.
Publicado: (2020)

Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
por: Bai, Wen, et al.
Publicado: (2023)

Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
por: Homayouni, Mansour
Publicado: (2009)

A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway: Anti-myeloma activity of a novel alkaloid in drug-resistant cells
por: Zhang, Bibo, et al.
Publicado: (2023)

Lipid Signaling in Ocular Neovascularization
por: Terao, Ryo, et al.
Publicado: (2020)

Omics Technologies and Neovascular Ocular Disorders
por: Petrovič, Daniel, et al.
Publicado: (2014)

Choroidal neovascularization secondary to ocular syphilis
por: Świerczyńska, Marta Paula, et al.
Publicado: (2021)

Potential epigenetic molecular regulatory networks in ocular neovascularization
por: Hu, Qiang, et al.
Publicado: (2022)

Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization
por: Sadiq, Mohammad Ali, et al.
Publicado: (2015)

Ferrochelatase is a therapeutic target for ocular neovascularization
por: Basavarajappa, Halesha D, et al.
Publicado: (2017)

An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization
por: Zhang, Chenchen, et al.
Publicado: (2022)

Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular Diseases
por: Benny, Ofra, et al.
Publicado: (2010)

Ocular Sarcoidosis Limited to Retinal Vascular Ischemia and Neovascularization
por: Dyer, Gawain, et al.
Publicado: (2016)

Blocking Ocular Sympathetic Activity Inhibits Choroidal Neovascularization
por: Martinez-Camarillo, Juan Carlos, et al.
Publicado: (2022)

DCZ0415, a small‐molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β‐catenin pathway in colorectal cancer
por: Agarwal, Sumit, et al.
Publicado: (2022)

Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization
por: Zhong, Yueyang, et al.
Publicado: (2021)

Lonafarnib Is a Potential Inhibitor for Neovascularization
por: Sun, Linlin, et al.
Publicado: (2015)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Shah, Nikunj J, et al.
Publicado: (2011)

Choroidal neovascularization after blunt ocular trauma in angioid streaks
por: Kubota, Masaomi, et al.
Publicado: (2013)

Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms
por: Gao, Fan, et al.
Publicado: (2016)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Ocular Coloboma With Choroidal Neovascular Membrane: A Case Report
por: Almasaud, Jluwi, et al.
Publicado: (2021)

Targeted Thrombospondin-1 Expression in Ocular Vascular Development and Neovascularization
por: Sorenson, Christine M., et al.
Publicado: (2021)

Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration
por: Qiu, Fangfang, et al.
Publicado: (2017)

Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice
por: Zeng, Peng, et al.
Publicado: (2015)

The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats
por: Ren, Chengda, et al.
Publicado: (2017)

Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization
por: Zhang, Yan, et al.
Publicado: (2017)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Coexisting choroidal neovascularization and active retinochoroiditis—an uncommon presentation of ocular toxoplasmosis
por: Hegde, Sharat, et al.
Publicado: (2015)

Flt3 Regulation in the Mononuclear Phagocyte System Promotes Ocular Neovascularization
por: Gao, Yushuo, et al.
Publicado: (2018)

Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma
por: Kim, Yung Hui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rn31k076p032c6ubc8aee98lc1